These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25034822)

  • 1. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease.
    Balci A; Sollie-Szarynska KM; van der Bijl AG; Ruys TP; Mulder BJ; Roos-Hesselink JW; van Dijk AP; Wajon EM; Vliegen HW; Drenthen W; Hillege HL; Aarnoudse JG; van Veldhuisen DJ; Pieper PG;
    Heart; 2014 Sep; 100(17):1373-81. PubMed ID: 25034822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of risk prediction scores in pregnant women with congenital heart disease.
    Kim YY; Goldberg LA; Awh K; Bhamare T; Drajpuch D; Hirshberg A; Partington SL; Rogers R; Ruckdeschel E; Tobin L; Venuti M; Levine LD
    Congenit Heart Dis; 2019 May; 14(3):470-478. PubMed ID: 30729681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive accuracy of three clinical risk assessment systems for cardiac complications among Chinese pregnant women with congenital heart disease.
    Fu Q; Lin J
    Int J Gynaecol Obstet; 2016 Aug; 134(2):140-4. PubMed ID: 27177511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center.
    Jastrow N; Meyer P; Khairy P; Mercier LA; Dore A; Marcotte F; Leduc L
    Int J Cardiol; 2011 Sep; 151(2):209-13. PubMed ID: 20659773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 3 Risk Estimation Methods for Predicting Cardiac Outcomes in Pregnant Women With Congenital Heart Disease.
    Lu CW; Shih JC; Chen SY; Chiu HH; Wang JK; Chen CA; Chiu SN; Lin MT; Lee CN; Wu MH
    Circ J; 2015; 79(7):1609-17. PubMed ID: 25959432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcomes in patients with pulmonary arterial hypertension associated with congenital heart disease.
    Ladouceur M; Benoit L; Radojevic J; Basquin A; Dauphin C; Hascoet S; Moceri P; Bredy C; Iserin L; Gouton M; Nizard J
    Heart; 2017 Feb; 103(4):287-292. PubMed ID: 27511447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac complications during pregnancy are better predicted with the modified WHO risk score.
    Pijuan-Domènech A; Galian L; Goya M; Casellas M; Merced C; Ferreira-Gonzalez I; Marsal-Mora JR; Dos-Subirà L; Subirana-Domènech MT; Pedrosa V; Baró-Marine F; Manrique S; Casaldàliga-Ferrer J; Tornos P; Cabero L; Garcia-Dorado D
    Int J Cardiol; 2015 Sep; 195():149-54. PubMed ID: 26043149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease?
    Bredy C; Deville F; Huguet H; Picot MC; De La Villeon G; Abassi H; Avesani M; Begue L; Burlet G; Boulot P; Fuchs F; Amedro P
    Eur Heart J Qual Care Clin Outcomes; 2023 Feb; 9(2):177-183. PubMed ID: 35472215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy in women with a cardiomyopathy: Outcomes and predictors from a retrospective cohort.
    Billebeau G; Etienne M; Cheikh-Khelifa R; Vauthier-Brouzes D; Gandjbakhch E; Isnard R; Nizard J; Komajda M; Dommergues M; Charron P
    Arch Cardiovasc Dis; 2018 Mar; 111(3):199-209. PubMed ID: 29102365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac function and cardiac events 1-year postpartum in women with congenital heart disease.
    Kampman MA; Balci A; Groen H; van Dijk AP; Roos-Hesselink JW; van Melle JP; Sollie-Szarynska KM; Wajon EM; Mulder BJ; van Veldhuisen DJ; Pieper PG;
    Am Heart J; 2015 Feb; 169(2):298-304. PubMed ID: 25641540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A growing problem: maternal death and peripartum complications are higher in women with grown-up congenital heart disease.
    Karamlou T; Diggs BS; McCrindle BW; Welke KF
    Ann Thorac Surg; 2011 Dec; 92(6):2193-8; discussion 2198-9. PubMed ID: 21962267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal right ventricular function, uteroplacental circulation in first trimester and pregnancy outcome in women with congenital heart disease.
    Siegmund AS; Kampman MAM; Oudijk MA; Mulder BJM; Sieswerda GTJ; Koenen SV; Hummel YM; de Laat MWM; Sollie-Szarynska KM; Groen H; van Dijk APJ; van Veldhuisen DJ; Bilardo CM; Pieper PG
    Ultrasound Obstet Gynecol; 2019 Sep; 54(3):359-366. PubMed ID: 30334300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular events more than 6 months after pregnancy in patients with congenital heart disease.
    Schultz H; Sobhani NC; Blissett S; Yogeswaran V; Hong J; Harris IS; Parikh N; Gonzalez J; Agarwal A
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37709299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital heart disease and pregnancy: maternal and fetal risks.
    Earing MG; Webb GD
    Clin Perinatol; 2005 Dec; 32(4):913-9, viii-ix. PubMed ID: 16325669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congenital heart disease and acquired valvular lesions in pregnancy].
    Horstkotte D; Fassbender D; Piper C
    Herz; 2003 May; 28(3):227-39. PubMed ID: 12756480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy in women with congenital heart disease: New insights into neonatal risk prediction.
    Rahnama N; Jemâa NB; Colson A; Pasquet A; de Castro LH; Debiève F; Pierard S
    Am Heart J; 2024 Jul; 273():148-158. PubMed ID: 38679190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective survey of adverse maternal and neonatal outcomes for parturients with congenital heart disease.
    Hidano G; Uezono S; Terui K
    Int J Obstet Anesth; 2011 Jul; 20(3):229-35. PubMed ID: 21641792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study.
    Balci A; Sollie KM; Mulder BJ; de Laat MW; Roos-Hesselink JW; van Dijk AP; Wajon EM; Vliegen HW; Drenthen W; Hillege HL; Aarnoudse JG; van Veldhuisen DJ; Pieper PG
    Am Heart J; 2011 Feb; 161(2):269-275.e1. PubMed ID: 21315208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of risk models predicting cardiac complications in pregnant women with congenital heart disease: a meta-analysis.
    Wang TKM; Lowe B; Hlohovsky S; O'Donnell C
    Intern Med J; 2020 Apr; 50(4):481-484. PubMed ID: 32270622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of risk stratification models for pregnancy in congenital heart disease.
    Denayer N; Troost E; Santens B; De Meester P; Roggen L; Moons P; Van Calsteren K; Budts W; Van De Bruaene A
    Int J Cardiol; 2021 Jan; 323():54-60. PubMed ID: 32931856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.